According to AlphaMoat, in August 2026 水木分子 (pharmolix.com) received 0 monthly visits — ranked #0 of 17,609 AI websites with traffic data, and #0 of 3,112 in Industry Services; its largest market is China (100.0% of visits).
What is 水木分子
Shuimu Molecule is a leader in biomedicine large models and agent platforms, building multimodal open-source large models and full-pipeline agents at the frontier of drug R&D, advancing drug development from target discovery to clinical research.
- 01BioMedGPT is an open-source biomedical multimodal reasoning large model that achieves 67.1% accuracy on the USMLE U.S. medical-licensing exam
- 02PharMolixFM is an all-atom foundation large model with 83.9% and 98.1% performance on the PoseBusters benchmark
- 03ChatDDFM is a commercial reasoning large model with biomedical knowledge
- 04ChatDD-Insight, ChatDD-Discovery, and ChatDD-Trial cover project research, molecule discovery, and clinical research
- 05PharMolixKG integrates tens of millions of authoritative entities and hundreds of millions of relational data
It provides model licensing and platform services to pharmaceutical companies and R&D institutions; the website does not publish a standardized price list and requires partnership consultation; the page lists no explicit product price figures.
12-Month Traffic Trend
| Month | Monthly visits | MoM |
|---|---|---|
| 2026-06 | 3.0K | — |
| 2026-07 | - | -100.0% |
| 2026-08 | 3.0K | — |
Visits by Country · Top 5
Popular in Industry Services
An AI recruiting platform unifying hiring workflows, talent relationships, and analytics.
+ Compare
A platform connecting specialists with model research, training, and evaluation projects
+ Compare
A conversational hiring agent that moves candidates from application through onboarding
+ Compare
A talent-intelligence platform using agents to support hiring, development, and workforce deployment
+ Compare
A clinician platform combining communication, telehealth, and AI-assisted documentation
+ Compare
An AI research and search platform built for professional investors
+ CompareData month: 2026-08 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.